D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 58 Citations 10,336 188 World Ranking 8982 National Ranking 653

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

His primary areas of study are Molecular biology, Cancer research, Transcription factor, Y box binding protein 1 and Angiogenesis. Hiroto Izumi has researched Molecular biology in several fields, including CAAT box and DNA damage. His Cancer research research integrates issues from Cell culture, Gene expression, Cancer cell, Immunology and Kinase.

As a member of one scientific family, Hiroto Izumi mostly works in the field of Transcription factor, focusing on Cell biology and, on occasion, Bicarbonate transporter protein, Metastasis and Monocarboxylate transporter. The Y box binding protein 1 study combines topics in areas such as Regulation of gene expression and DNA repair. His Angiogenesis research includes themes of Tumor necrosis factor alpha, Basic fibroblast growth factor and Interleukin 8.

His most cited work include:

  • Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy (484 citations)
  • Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells POSSIBLE ROLES OF SP-1 (435 citations)
  • The pleiotropic functions of the Y-box-binding protein, YB-1. (414 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cancer research, Molecular biology, Pathology, Transcription factor and Internal medicine. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Cell culture, Gene knockdown and Cell growth. His biological study spans a wide range of topics, including CAAT box, DNA, DNA damage and Transcription, Gene.

His Pathology study integrates concerns from other disciplines, such as Survival analysis, Lung and Adenocarcinoma. In his research on the topic of Transcription factor, Transactivation is strongly related with Promoter. His studies in Internal medicine integrate themes in fields like Endocrinology and Oncology.

He most often published in these fields:

  • Cancer research (32.00%)
  • Molecular biology (25.14%)
  • Pathology (17.14%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (32.00%)
  • Lung (11.43%)
  • Internal medicine (16.00%)

In recent papers he was focusing on the following fields of study:

Hiroto Izumi mainly investigates Cancer research, Lung, Internal medicine, Pharmacology and Intratracheal instillation. His Cancer research research incorporates elements of Protein kinase B, Phosphorylation, Gene expression, Cancer cell and Downregulation and upregulation. His Downregulation and upregulation research focuses on Glioma and how it relates to Cell culture and Cell growth.

His work in the fields of Pulmonary toxicity overlaps with other areas such as Surfactant protein D. His Internal medicine research includes elements of Gastroenterology, Endocrinology and Antibody. His research is interdisciplinary, bridging the disciplines of Molecular biology and Gene.

Between 2017 and 2021, his most popular works were:

  • Complex consisting of antisense DNA and β-glucan promotes internalization into cell through Dectin-1 and hybridizes with target mRNA in cytosol. (9 citations)
  • Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance. (5 citations)
  • Induction of potent cell growth inhibition by schizophyllan/K-ras antisense complex in combination with gemcitabine (4 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

Hiroto Izumi mainly investigates Cancer research, Cell growth, Protein kinase B, Gene silencing and Phosphorylation. His research in Cancer research intersects with topics in Cancer cell, Internalization and Drug resistance. His Protein kinase B study incorporates themes from Differentiation-inducing factor, Cell culture, Downregulation and upregulation and Glioma.

Hiroto Izumi interconnects Tamoxifen, Breast cancer, Fulvestrant and Everolimus in the investigation of issues within Phosphorylation. His Cytoplasm study introduces a deeper knowledge of Cell biology. He has included themes like Replication protein A, Binding protein, Immunoprecipitation, Ribonucleoprotein and DNA in his Cell biology study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

Hiroto Izumi;Takayuki Torigoe;Hiroshi Ishiguchi;Hidetaka Uramoto.
Cancer Treatment Reviews (2003)

750 Citations

The pleiotropic functions of the Y-box-binding protein, YB-1.

Kimitoshi Kohno;Hiroto Izumi;Takeshi Uchiumi;Megumi Ashizuka.
BioEssays (2003)

663 Citations

Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells POSSIBLE ROLES OF SP-1

Masahiro Ryuto;Mayumi Ono;Hiroto Izumi;Shigeo Yoshida.
Journal of Biological Chemistry (1996)

636 Citations

Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress.

Tadahisa Shono;Mayumi Ono;Hiroto Izumi;Sei Ichiro Jimi.
Molecular and Cellular Biology (1996)

389 Citations

Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.

Tomoko Ise;Gunji Nagatani;Toshihiro Imamura;Ken Kato.
Cancer Research (1999)

252 Citations

P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA.

Yoichiro Yoshida;Hiroto Izumi;Takayuki Torigoe;Hiroshi Ishiguchi.
Cancer Research (2003)

236 Citations

Review of toxicity studies of carbon nanotubes.

Norihiro Kobayashi;Hiroto Izumi;Yasuo Morimoto.
Journal of Occupational Health (2017)

215 Citations

Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.

T Okamoto;H Izumi;T Imamura;H Takano.
Oncogene (2000)

212 Citations

Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.

Hiroto Izumi;Mayu Takahashi;Hidetaka Uramoto;Yoshifumi Nakayama.
Cancer Science (2011)

197 Citations

Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas

Kazunori Shibao;Hiroshi Takano;Yoshifumi Nakayama;Keisuke Okazaki.
International Journal of Cancer (1999)

194 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hiroto Izumi

Michihiko Kuwano

Michihiko Kuwano

Kyushu University

Publications: 49

Kimitoshi Kohno

Kimitoshi Kohno

University of Occupational and Environmental Health Japan

Publications: 45

Mayumi Ono

Mayumi Ono

Kyushu University

Publications: 40

Takeshi Uchiumi

Takeshi Uchiumi

Kyushu University

Publications: 33

Stefano Fais

Stefano Fais

Istituto Superiore di Sanità

Publications: 33

Des R. Richardson

Des R. Richardson

Griffith University

Publications: 29

Seiji Naito

Seiji Naito

Kyushu University

Publications: 24

Antony W. Braithwaite

Antony W. Braithwaite

University of Otago

Publications: 18

Florian Lang

Florian Lang

University of Tübingen

Publications: 17

Chuan Dong

Chuan Dong

Shanxi University

Publications: 16

Henrik Clausen

Henrik Clausen

University of Copenhagen

Publications: 15

Shaomin Shuang

Shaomin Shuang

Shanxi University

Publications: 15

Xiao-Qiu Zhou

Xiao-Qiu Zhou

Sichuan Agricultural University

Publications: 13

Stephen Safe

Stephen Safe

Texas A&M University

Publications: 13

Angelo De Milito

Angelo De Milito

Karolinska Institute

Publications: 12

Yoshinao Oda

Yoshinao Oda

Kyushu University

Publications: 12

Trending Scientists

Ivan Glesk

Ivan Glesk

University of Strathclyde

Haining Tian

Haining Tian

Uppsala University

Lian-Wen Qi

Lian-Wen Qi

China Pharmaceutical University

Mauro Piacentini

Mauro Piacentini

University of Rome Tor Vergata

Lisenka E.L.M. Vissers

Lisenka E.L.M. Vissers

Radboud University Nijmegen

Pedro H. S. Brancalion

Pedro H. S. Brancalion

Universidade de São Paulo

Kim S. McKim

Kim S. McKim

Rutgers, The State University of New Jersey

Tobias B. Huber

Tobias B. Huber

Universität Hamburg

Roderick A. Heelis

Roderick A. Heelis

The University of Texas at Dallas

Jeffrey G. Ojemann

Jeffrey G. Ojemann

University of Washington

John K. Olynyk

John K. Olynyk

Edith Cowan University

John F. Seymour

John F. Seymour

Peter MacCallum Cancer Centre

R. Gilberto Gonzalez

R. Gilberto Gonzalez

Harvard University

Michael B. Wheeler

Michael B. Wheeler

University of Toronto

Stanley Cavell

Stanley Cavell

Harvard University

Howard Yee

Howard Yee

University of Toronto

Something went wrong. Please try again later.